New Program at Stanford Treats Patients with Tumor-multiplying Diseases
Rare multi-system conditions like neurofibromatosis are challenging to treat. Daniel Knodel finds Stanford's multi-specialty approach to care simplifies his life.
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Get the iPhone MyHealth app »
Get the Android MyHealth app »
The Stanford Clinical Neurogenetic Oncology Program is the first clinic in Northern California to offer world-class care for patients with clinical neurogenetic disorders, which can cause tumors to grow inside the brain, spinal cord, organs, skin and skeletal bones.
Clinical neurogenetic syndrome is a broad term for a group of neurologic (brain, spine, and peripheral nerve) disorders. These diseases are life-long conditions that can cause tumors to grow inside the brain, spinal cord, organs, skin, and skeletal bones.
Types of clinical neurogenetic syndromes include the following:
A rare multi-system genetic disease that causes non-malignant tumors to grow in the brain and on other vital organs such as the kidneys, heart, eyes, lungs, and skin.
Inherited disorders of the nervous system which affect how nerve cells form and grow, causing tumors to grow on nerves.
A rare congenital neurological and skin disorder characterized by a port-wine stain located on the face, typically near or around the eye and forehead area. Individuals may also experience seizures, muscle weakness, changes in vision, and mental retardation.
A genetic disorder that results in tumors, called schwannomas, on peripheral nerves throughout the body.
A hereditary condition associated with blood vessel tumors of the brain, spinal cord, and eye.
A genetic disorder that leads to abnormal blood vessel formation in the skin, mucous membranes, and often in organs, such as the lungs, liver, and brain.
Rare multi-system conditions like neurofibromatosis are challenging to treat. Daniel Knodel finds Stanford's multi-specialty approach to care simplifies his life.
When she learned she had a malignant brain tumor, Marjorie Paulsen appreciated both the medical treatment at Stanford and the positive attitude of her care team.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
For your convenience, you may check in for all same-day appointments at the Stanford Neuroscience Health Center through a centralized, check-in desk near the front lobby. In addition to all outpatient services, you also can access onsite pre-surgery consultations at the center.
New patients should call the Neurogenetics Program Coordinator at 650-736-0262 to schedule an appointment.
International Patients
Phone: +1 650-723-8561
Email: IMS@stanfordhealthcare.org
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8:30 a.m. – 5 p.m.
Phone: 1-800-800-1551, 24 hours - 7 days a week
Stanford Health Care provides comprehensive services to refer and track patients, as well as provides the latest information and news for physicians and office staff. For help with all referral needs and questions visit Referring Physicians.
Refer any adult patient with a clinical neurogenetic autosomal dominant or autosomal recessive genetic disease to the Clinical Neurogenetics Program Coordinator at 650-736-0262 or VeeVo@stanfordmed.org.
To request an appointment, call:
Phone:
650-723-6469
Patient Care Coordinator:
650-736-0262
Transfer Center/LifeFlight:
1-800-800-1551
Fax:
650-320-9443
MD Help Line:
1-866-742-4811